Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-04-16

FDA Approved: ALLEGRA HIVES 24HR — Supplemental Application (Chattem, Inc.)

View source ↗

Summary

FDA approved a supplemental application for ALLEGRA HIVES 24HR (fexofenadine hydrochloride) from Chattem, Inc., authorizing an approved change to the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ALLEGRA HIVES 24HR (fexofenadine hydrochloride)

Snippet

SUPPL AP for ALLEGRA HIVES 24HR (FEXOFENADINE HYDROCHLORIDE)